InsiderClue
Insiders · Profile

Shook David

Chief Medical Officer at Lyell Immunopharma · See Remarks at Nkarta. Filing since 17 Jan 2023. CIK 0001959742

LYEL Lyell Immunopharma, Inc. Chief Medical Officer · 2 trades NKTX Nkarta, Inc. See Remarks · 6 trades
Company
Date
Role
Action
Shares
Amount
Of holding
LYEL Lyell Immunopharma, Inc.
10 Sep 2026
Chief Medical Officer
Sold at will
500
$6.35K
2.4%
LYEL Lyell Immunopharma, Inc.
10 Jun 2026
Chief Medical Officer
Sold at will
1,977
$24.99K
8.6%
NKTX Nkarta, Inc.
15 Jan 2025
See Remarks
Sold at will
8,638
$19.00K
4.3%
NKTX Nkarta, Inc.
18 Jun 2024
Chief Medical Officer
Sold at will
456
$2.55K
0.4%
NKTX Nkarta, Inc.
16 Jan 2024
Chief Medical Officer
Sold at will
3,552
$31.04K
3.0%
NKTX Nkarta, Inc.
21 Aug 2023
Chief Medical Officer
Sold at will
1,331
$2.44K
2.2%
NKTX Nkarta, Inc.
20 Jun 2023
Chief Medical Officer
Sold at will
439
$2.13K
0.7%
NKTX Nkarta, Inc.
17 Jan 2023
Chief Medical Officer
Sold, plan not stated
175
$960.75
0.3%
8 decisions on file.